Patogénese da aterosclerose 1ª parte

Autores

  • José Manuel Silva Assistente Hospitalar de Medicina Interna, Serviço de Medicina II dos Hospitais da Universidade de Coimbra
  • Nuno Devesa Interno do Internato Complementar de Medicina Interna, Serviço de Medicina II dos Hospitais da Universidade de Coimbra
  • Elsa Gaspar Interno do Internato Complementar de Medicina Interna, Serviço de Medicina II dos Hospitais da Universidade de Coimbra

Palavras-chave:

aterosclerose, patogénese, cronologia, teorias

Resumo

Os autores abordam sumariamente a cronologia da doença aterosclerótica para depois reverem, tentando integrá-las na evolução da placa de ateroma, as várias teorias da aterogénese. Nesta primeira parte são referenciadas as teorias da resposta à retenção, lipídica, monoclonal, da encrustação, da resposta à lesão e oxidativa.

Downloads

Não há dados estatísticos.

Referências

Henry P D, Chen C-11. lnflammatory mechanisms of atheroma formation. lnfluence of fluid mechanics and lipid-dcrived inflammatory mediators. Am J Hypertens 1993; 6: 328S-334S

Ross R. The pathogenesis of atherosclerosis. A perspective for the 1990s. Nature 1993; 362: 801-809.

Nachman R L. Thrombosis and atherogenesis: molecular connections. Blood 1992; 79: 1897-1906

Visser M R, Vercellotti G M, McCarthy J B, Goodman J L, Herbst T J, Furcht LT, Jacob H S. Herpes simplex virus inhibits endothelial cell attachment and migration to extracellular matrix proteins. Am J Pathol 1989; 134: 223-230.

Koenig W, Sund M, Frõhlich M, Fischer H-G, Lõwel H, Dõring A. Hutchinson W, Pepys M. C-Reactive protein, a sensitive marker of inflammation, predicts risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-242.

Liuzzo G, Biasucci L, Gallimore R, Grillo R, Rebuzzi A, Pepys M, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.

Biasucci L, Liuzzo G, Grillo R, Caligiuri G, Rebuzzi A, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A. Elevated leveis of C­ Reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99: 855-860.

Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, Ogawa S. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a lirst Q-wave acute myocardial infarction. Circulation 1997; 96: 778-784.

Ridker P, Rifai N, Pfeíler M. Sacks F, Moye L, Goldman S, Flaker G, Braunwald E. lnflamation, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998; 98: 839-844.

Bierman E L. Atherosclerosis and other forms of arteriosclerosis" Em: "Harrison's principles of internal medicine, McGraw-Hill, New York 1991; 12th ed.; 992-1001.

Holman RL, McGill H C Jr, Strong J P, Geer J C. The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the 20th century. Am J Pathol, 1958; 34: 209-229

Rodrigues M F, Mendonça M C, Moreira A. Costa J P. Lesões macroscópicas de aterosclerose em jovens. O Médico 1989; 121: 138-141.

Anónimo. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the pathological determinants of atherosclerosis in youth (PDAY) research group. JAMA 1990; 264: 3018-3024,

Berliner J A, Gerrity R G. Pathology of atherosclerosis". Em: Lusis A J, Rotter J 1, Sparkes R S, (eds.): "Molecular genetics of coronary artery disease. Candidate Genes and processes in atherosclerosis, Monogr Hum Gene!, Karger, Base! 1992; 14: 1-17.

Mathur K S, Kashyap S K, Kumar V Correlation of lhe extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 1963; 27: 929-934.

Smith E B. Fibrinogen, fibrin, and fibrin degradation products in relation to atherosclerosis. Clin Haematol 1986; 15: 357-370.

Bobryshev Y V, Lord R S, Warren B A. Calcified deposit formation in intimai thickenings of the human aorta. Atherosclerosis 1995; 118: 9-21.

Guyton J R, Klemp K F. Developmcnt of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Arterioscl Thromb 1994; 14: 1305-1314.

McGill H C Jr. Fatty streaks in lhe coronary arteries and aorta. Lab lnvest 1968; 18: 560-564.

Moossy J. Pathology of cerebral atherosclerosis. Stroke 1993; 24 (suppl 1): 1 22-1 23.

Bianciardi G, Simoes C, Resi L, Tanganelli P, Weber G. WHO­ ISFC PBDAY Study, 1. Distribution of lipid and raised atherosclerotic lesions in the aortas of young people (5-34) of various ethnic origins. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994: 109 (1,2): 101

Freedman D S, Newman W P Ili, Tracy R E, Voors A E, Srinivasan S R, Webber L S, Restrepo C, Strong J P, Berenson G S. Black­ white differences in aortic fatty streaks in adolescence and early adulthood: the Bogalusa Heart Study. Circulation 1988; 77: 856-864.

Stehbens W E. The lipid hypothesis of atherogenesis. R G Landes Company, Austin, 1993, 185 pp

Schwartz C J, Valente A J, Sprague E A. A modem view of atherogenesis. Am J Cardiol 1993; 71: 98-148.

Virchow R. Phlogose und thrombose in gefassystem, gesammelte abhanlungcn zur wisseschaftlichen medizin. Frankfurt-am-Main, Germany: Meidinger Sohn. 1856: 458.

Stary H C. Macrophages, macrophage foam cells, and eccentric intimai thickening in the coronary artery intima of young children. Atherosclerosis 1987; 64: 91-108.

Simionescu N, V.asile E, Lupu F, Popescu G, Simionescu M. Prelesional events in atherogenesis: accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidaemic rabbit. Am J Pathol 1986; 123: 109-125.

Feldman D L, Hoff H, Gerrity R G. Immunohistochemical localization of apoprotein B in aortas from hyperlipidemic swine: preferential accumulation in lesion-prone areas. Arch Pathol Lab Med 1984; 108: 817-822.

Haberland M E, Steinbrecher U P. Modified low-density lipoproteins: diversity and biological relevance in atherogenesis. Em: Lusis A J, Rotter J I, Sparkes R S, (eds.): Molecular genetics of coronary artery disease. Candidate Genes and processes in atherosclerosis, Monogr Hum Genet, Karger, Base! I 992; 14: 35- 61.

Thompson W D, Smith E B. Atherosclerosis and the coagulation system. J Pathol 1989; 159: 97-106.

Navab M, Berliner J, Watson A, Hama S, Territo M, Lusis A, Shih D, Lenten B, Frank J, Demer L, Edwards P, Fogelman A The yin and yang of oxidation in the development of the fatty streak. Arteriosel Thromb Vasc Biol 1996; 16: 831-842.

Smith E. Fibrinogen und Atherosklerose. Wien Klin Wochenschr 1993; 105: 417-424.

Chen Y-L, Jan K-M, Lin H-S, Chien S. Ultrastructural studies on macromolecular permeability in relation to endothelial cell turnover. Atheroscleros is 1995; 118: 89-104.

Kao C, Chen J, Kuo J, Yang V. Visualization of the transpor! pathways of low density lipoproteins across the endothelial cells in the branched regions of rat arteries. Atherosclerosis. 1995; 116: 27-41

Nielson L B. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. Atherosclerosis 1996; 123: 1-15.

Radhakrishnamurthy B, Srinivasan S R, Vijayagopal P, Bercnson G S. Arterial wall proteoglycans; biological properties related to pathogenesis of atherosclerosis. Eur Heart J 1990; 11 (suppl E): 148-157.

Davies M J, Woolf N, Rowles P M, Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 1988; 60: 459-464.

Williams K J, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arteriosel Thromb Vasc Biol 1995; 15: 551-

Williams K, Tabas 1. The response-to-retention hypothesis of atherogenesis reinforced. Curr Op Lipidol 1998; 9: 471-474.

Bondjers G, Camejo G, Fager G, Camejo E H, Lusting F, Olsson U, Wiklund O. Binding od apolipoprotein B and PDGF to arterial proteoglycans. 62nd EAS Congress Abstracts, 1993, p. 6.

Camejo G, Hurt-Camejo E, Olsson U, Rosegeren B, Fager G, López F, Bondjers G. lnteractions of proteoglycans and lipoproteins. Xth International Symposium on Atherosclerosis· Abstracts, Atherosclerosis 1994; 109 (1,2): 170.

Srinivasan S R, Xu J-H, Vijayagopal P, Radhakrishnamurthy B, Berenson G S. Low-density lipoprotein binding affinity of arterial chondroitin sulfate proteoglycan modulates cholesteryl ester accumulation in macrophages. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994; 109 (1,2): 97.

Cardoso L E, Mourão P A. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscl Thromb 1994; 14: 115-124.

Waickus C M. Oxidized LDL, atherogenesis and antioxidants. Am Fam Physician 1993; 48: 718-720.

Navab M, !-lama S Y, Nguyen T B, Fogelman A M. Monocyte adhesion and transmigration in atherosclerosis. Coronary Artery Dis 1994; 5: 198-204.

Badimon J J, Fuster V, Chesebro J H, Badimon L. Coronary atherosclerosis. A multifactorial disease. Circulation 1993: 87 (suppl II): II 3- II 16.

Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986; 314: 488-500.

Schwartz C J, Valente A J. The monocyte-macrophage: introduction and overview. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994; 109 ( 1,2): 330.

Wada T, Kodaira K, Fujishiro K,Maie K, Tsukiyama E, Fukumoto T, Uchida T, Yamazaki S, Correlation of ultrasound-measured common carotid artery stiffness with pathological findings. Arterioscl Thromb 1994; 14: 479-482.

lp J H, Fuster V, Badimon L, Badimon J. Taubman M B, Chesebro J H. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667-1687.

Toborek M, Hennig B. Vitamin E attenuates induerion of elastase­ like activity by tumor necrosis factor-a, cholestan-3P.5a,6P-triol and linoleic acid in cultured endothclial cells. Clin Chim Acta 1993; 215: 201-211.

Amaro A, Gude F, González-Juanatey .1 R, lglesias C, Fernández­ Vázquez F, Varela-Duran J, Castellanos C, Gil M. Activity of leucocyte elastase in women with coronary artery disease documented using angiography. J Cardiovasc Risk 1995; 2: I 49- 153.

Shah P. Inflammation, metalloproteinases, and increased protcolysis. An emerging pathophysiological paradigm in aortic aneurysm. Circulation 1997; 96: 2115-2117.

Libby P, Hansson G K. Biology of discase. lnvolvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab lnvest 1991. 64: 5-15.

Stemme S, Hansson G K. lmmune mechanisms in atherosclerosis. Coronary Artery Dis 1994, 5: 2 16-222.

Navab M, lmes S S, Hama S Y, Hough G P. Ross L A, Bork R W, Valente A J, Berliner J A, Drinkwater D C, Laks H, Fogelman A

M. Monocyte transmigration induced by modification of low density lipoprotein in cococultures of human aortic wall cells is due to induction of monocyte chemotatic protein I synthesis and is abolished by high density lipoprotein. J Clin Invest 1991; 88: 2039-2046.

Van der Wal A, Das P K, Tigges A J. Bccker A E. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 1992; 141: 1427-1433.

Libby P, Salomen R N, Paync D D. Schoen F J. Pober JS. Functions of vascular wall cells related to lhe development of transplanlation­ associated coronary arteriosclerosis. Transplantation Proc I 989; 21: 3677-3684.

Terrilo M C, Berlincr J A, Navab M. Cellular lnteractions of lhe arterial wall. Em: Lusis A J, Rotter J I, Sparkcs R S, (eds.): Molecular genetics of coronary artery disease. Candidate Genes and processes in atherosclerosis, Monogr Hum Gene!, Karger, Base! 1992; 14: 18-34.

Carlos T, Kovaeh N, Schwarlz B, Rosa M, Newman B, Wayner E, Benjamin C. Osborn L, Lobb R, Harlan J. Human monocyles bind to two cytokinc-induced adhesive ligands on cultural human endothelial cells: endothelial leukocyte adhesion molecule-1 and vascular adhesion molecule-1. Blood 199 I; 77: 2266-2271.

Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi­ Rosso G, Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to Iymphocytes. Cell 1989; 59: 1203-1211.

Cybulsky M I, Gimbrone M A Jr. Endothelial expression of a mononuclear leukocyle adhesion molecule during atherosclerosis. Science 1991; 251: 788-791.

Li H, Cybulsky M, Gimbrone M .Ir, Libby P. An atherogenic diet rapidly induces VCAM-1. a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioseler Thromb 1993: 13: 197-204.

Wood K M, Cadogan M D. Ramshaw A L, Parums D V. The distribution of adhesion molecules in human atherosclerosis. Histopathology 1993; 22: 437-444.

Hackman A, Abe Y, lnsull W, Pownall H, Smith L, Dunn K, Gotto A, Ballantyne C. Leveis of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996; 93: 1334-1338.

Nakai K. ltoh C, Kawazoe K, Miura Y, Sotoyanagi H, Hotta K. ltoh T, Kamala .1, Hiramori K. Concentration of soluble vascular cell edhesion molecule-1 (VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta. Coronary Artery Ois 1995; 6: 497-502.

Katsuda S, Coltrera M D, Ross R, Gown A M. Human Atherosclerosis. IV. lmmunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol 1993, 142 1787-1793.

Anitskchow N, Chalalow S. Über experimentelle cholesterinase und ihre bedeutung fur die entstehung einiger palhologischer prozesse.Zentralbl Allg Palhal Path Anat 1913;24:1-9.

Libby P, Galis Z. Shin W S. Liao J K. Cytokines as modulators of atherosclerosis. 62nd LAS Congress Abstracts. 1993. pág 101

Davies P F, Olesen S P, Clapham D E. Morrei E M. Schoen F J. Endothelial communication. State of the art lecture. Hypertension 1988; 11: 563-572.

Roth M. The vascular nervous skeleton: a disregarded factor of vascular pathology. Atherosclerosis 1994; 108: 1-3.

Davies M. Reactive oxygen species, metalloproteinases, and plaque stability. Circulation 1998; 97: 2382-2383.

Rosenfeld M E, Peste! E. Cellularity of atherosclerotic lesions. Coronary Artery Dis 1994; 5: 189-197.

Bendill E P, Benditt J M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973; 70: 1753.

Sabei B E. lncreased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox. Circulation 1999; 99: 2496-

Robenek H, Pataki M. Endocytosis of oxidized LDL and reversibility of migration inhibition in macrophage-derived foam cells in vitro.62nd EAS Congress Abstracts 1993, p83.

Thompson G R. A handbook of hyperlipidaemia. Current Science Ltd, London, 1990.

Falk E. Coronary thrombosis: pathogenesis and clinicai implications. Am J Cardiol 1991: 68: 28B-35B.

Fustcr V, Badimon L, Badimon J J, Chesebro J H. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 1992; 326: 242-250.

Van Aken P J, Emeis J J. Organization of experimentally induced arterial thrombosis in rals from two weeks until len months: lhe development of an arteriosclerotic lesion and the occurrence of rethrombosis. Artery 1983; li: 384-399.

Davies M J, Thomas A C. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Hearl J 1985; 53: 363-373.

Buja L M Willerson J T. Clinicopathologie correlates of acute ischemic heart disease syndromes. Am J Cardiol 1981; 47: 343- 356.

Davies M J, Woolf N, Robertson W B. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br 1-leart J 1976; 38: 659-664.

Rokitansky C. A manual of pathological analomy. London: Sydenham Society 1852; vol. IV: 265-275.

Davies M J, Bland M J, Hangartner W R, Angelini A, Thomas A C. Factors influencing lhe presenec ar absenee of acule coronary lhrombi in sudden ischemic death. Eur Heart .l 1989: 10: 203- 208.

Vel ican C, Vel ican D. The precursors of coronary atherosclerotic plaques in subjects up to 40 years old. Atherosclerosis 1980; 37: 33-46.

Davics M J. Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Eng! J Med 1984; 31O: 1137-1140.

Folkman J. Clinicai applications of research on angiogenesis. N Eng! J Med 1995; 333 1757-1763.

Wilcox J.Thrombotic mechanisms in atherosclerosis.Coronary Artery Dis 1994; 5: 223-229.

lsner J. Cancer and atherogenesis. The broad mandate of angiogenesis. Circulation 1999; 99: 1653- 1655.

Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983: 50: 127-134.

Hunt B J. The relation betwcen abnormal hemostatic function and the progression of coronary disease. Curr Op Cardiol 1990: 5: 758-765.

Hatton M W, Moar S L, Richardson M. Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface. Correlation of uptake of fibrinogen and antithrombin Ili with thrombin generation by the exposed subendothelium. Am J Pathol I 989; I 35: 499-508.

Lupu F, Bergonzelli G E, Heim D A, Cousin E, Genton C Y, Bachmann F, Kruithof E K O. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993; I 3: I 090-1100.

Prins M H, Hirsh J. A critical review of the relationship between impaired fibrynolisis and myocardial infarction Am Heart J 1991; 122: 545-551.

Padró T, Emeis J J, Steins M, Schmid K W, Kienast J. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to lhe presence and severity of atherosclerotic disease. Arterioscl Thromb Vasc Biol 1995; 15: 893-902.

Naito M, Hayashi T, Kuzuya M, Funaki C, Asai K, Kuzuya F. Effects of fibrinogen and fibrin on lhe migration of vascular smooth muscle cells in vitro.Atherosclerosis I 990;83:9-14.

Grandaliano G, Valente A J, Abboud H E. A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. J Exp Med 1994; 179: 1737-1741.

Shavit R, Hruska K, Kahn A, Wilner G D. Thrombin chemotatic stimulation of HL-60 cells: studies on thrombin responsiveness as a function of differentiation. J Cell Physiol 1987; 13 I: 255-261.

Loscalzo J. The relation between atherosclerosis and thrombosis.Circulation 1992; 86 (suppl III): 95-99.

Harlan J M, Thompson P J, Ross R R, Pope D F B. Alpha­ thrombin induces release of platelet derived growth factor-like molecule(s) by cultured human endothelial cells. J Cell Biol 1986; 103: 1129-1133.

Shultz PJ, Knauss T C, Mene P Abboud H E. Mitogenic signals for thrombin in mesangial cells: regulation of phospholipase C and PDGF genes. Am J Physiol I 989; 257: F366-F374.

Weiss R H, Maduri M. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem 1993; 268: 5724-5727.

I 04. Fishel R S, Thourani V, Eisenberg S J, Shai S Y, Corson M A, Nabel E G, Bernstein K E, Berk B C. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smouth muscle cells. Possible mediator of the response to vascular injury. J Clin lnvest I 995; 95: 377-387.

Chesebro J H. Webster M W I. Smith H C, Frye R L. Holmes D R, Reeder G S, Bresnaham D R. Nishimura R A, Clements I P, Bardsley W T. Grill D E, Fuster V Antiplatelet therapy in coronary disease progression: reduced infarction and new lesion formation. Circulation 1989; 80 (suppl II); 11-266, abstract.

Martin J F, Bath P M. Burr M L. lnfluence of platelet size on outcome after myocardial infarction. Lancet 199 I; 338: 1409-1411.

McGill D A. Ardlie N G. Abnormal platelet reactivity in men with premature coronary heart disease. Coronary Artery Dis 1994: 5: 889-900.

Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn P F. 13lood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84: 613-617.

Trip M D, Cats V M, van Capelle F J L, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med I 990; 322: 1549-1554.

Willingen G. Gorter G, Akkerman J-W. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules. Arterioscl Thromb 1994; 14: 41-46.

Ross R, Harker L.Hyperlipidemia and atherosclerosis.Science 1976: 193 1094-1100.

Reidy M A. A reassessment of endothelial injury and arterial lesion formation. Lab lnvest 1985: 53: 513-520.

Tamagaki T, Sawada S, lmamura H, Tada Y, Yamasaki S, Toratani A, Saio T, Komatsu S, Akamatsu N, Yamagami M, Kobayashi K. Kato K, Yamamoto K, Shirai K, Yamada K, Higaki T, Nakagawa K, Tsuji H, Nakagawa M. Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells. Atherosclerosis I 996; 123: 73-82.

Schwartz S M, Reidy M A. Commom mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension. Hum Pathol 1987; 18: 240-247.

Kozar R A, McKeone B J, Pownall H J. Free radical-induced alterations in endothelial cell function. J Surg Res 1994; 56: 32- 36.

Raij L. Hypertension, endothelium, and cardiovascular risk factors. Am J Med I 99 I; 90 (suppl 2A): 13- I 8.

Heistad D D, Armstrong M L, Baumbach G L, Faraci F M. Sick vessel syndrome. Recovery of atherosclerotic and hypertensive vessels. Hypertension 1995; 26: 509-513.

Nobuyoshi M, Tanaka M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, Kim K, Shindo T, Kimura K. Progression of coronary atherosclerosis: is coronary spasm related to progression?. J Am Coll Cardiol 1991; 18: 904-910.

Nobuyoshi M, Abe M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, Shindo T, Kimura K, Nakamura T, Nakagawa Y, Shiode N, Sakamoto A, Kakura H, lwasaki Y, Kim K, Kitaguchi S. Statistical analysis of clinicai risk factors for coronary artery spasm: identification of lhe most important determinant. Am Heart J 1992; 124: 32-38.

Fuster V, Badimon L, Badimon J J, Chesebro J H. The pathogenesis of coronary artery disease and lhe acute coronary syndromes (2nd of two parts). N Eng! J Med 1992: 326: 310-318.

Casscells W, Eastman J D. Grand Round. Thrombus and unstable angina. Lancei 1993; 342: 1151-1155.

Daugherty A. Lipoprotein receptors in arterial tissue: relation to the pathology of atherosclerosis. Coronary Artery Dis 1994: 5: 211-2 I 5.

Goldstein J L, Brown M S, Anderson R G W, Russell D W, Schneider W J. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1985; 1: 1-39.

Goldstein J L, Brown M S. Regulation of low density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis. Circulation 1987; 76:504-507.

Tabas 1, Weiland D, Tall A. Stimulation of cholesteryl ester storage in macrophagelike J774 cells by unmodified human low density lipoprotein. Proc Natl Acad Sci USA 1985: 82: 416- 420.

Sparrow C P, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 1989; 264: 2599-2604.

I 27. Testa, R, Bonfigli A, Pieri C, Marra M, Sirolla C, Manfrini S, Testa 1. A significant relationship between plasminogen activator inhibitor type-1 and lipoprotein(a) in non-insulin-dependent diabetes mellitus without complications. lnt J Clin Lab Res 1998: 28: 187-191.

Geng Y-J, Nygren S, Hansson G K. Detection of scavenver receptor expression in atherosclerotic plaques and macrophage foam cells by specific antibodies. 62nd EAS Congress Abstracts 1993, pág, 63.

Brown M S, Goldstein J L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.

Kristensen T, Moestrup S K, Gliemann J, Bendtsen L, Sand O, Sottrupjensen L. Evidence that the newly cloned low-density­ lipoprotein receptor related protein (LRP) is the alpha-2- macroglobulin receptor. FEBS Leu 1990; 276: 151-155.

Marz W, Beckmann A, Scharnagl H, Siekmeier R, Mondorf U, Held !, Schneider W, Preissner K, Curtiss L, Gross W et ai. Heterogeneous lipoprotein(a) size isoforms differ by their interactions with the low density lipoprotein receptor and the low density lipoprotein receptor-related · protein/alpha(2)­ macroglobulin receptor. Febs Lett 1993; 325: 271-275.

Luoma J, Hiltunen T, Slirkioja T, Moestrup S K, Gliemann J, Kodama T, Nikkari T, Yla-Herttuala S. Expression of a2- macroglobulin receptor/LDL receptor-related protein and svaccnger receptor in human atherosclerotic lesions. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994; 109 ( 1,2): 115.

Stanton L W, White R T, Bryant C M, Protter A A, Endemann G. A macrophage Fc receptor for lgG is also a receptor for oxidized low density lipoproteins. J Biol Chem 1992; 267: 22446- 22451.

Endemann G, Stanton L W, Madden K S, Bryant C M, White R T, Protter A A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993; 268: 11811-11816.

Bihain B E, Yen F T. The lipolysis stimulated receptor: a gene at last. Curr Op Lipidol 1998: 9: 221-224.

Roach P D, Hirata F, Triantafilidis C, Neste] PJ. Rat Jung expresses a LDL-binding protein which is distinct from the LDL receptor. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994: 109 (1,2): 111.

Heinecke J W. Cellular mechanisms for the oxidative modifícation of lipoproteins: implications for atherogenesis. Coronary Artery Ois !994; 5: 205-210.

l.iao F, Berliner J A, Mehrabian M, Navab M, Demer L L, Lusis A J, Fogelman A M. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin lnvest 1991; 87: 2253-2257.

Steinberg D, Parthasarathy S, Carew T E, Khoo J C, Witztum J L. Beyond cholesterol. Modifícations of low-density lipoprotein that increase its atherogenicity. N Eng! J Med 1989: 320: 915- 924.

Chapman M J, Prassl R, Laggner P, Lund-Katz S, Phillips M C, Flament C, Goulinet S, Nigon F, Rouis M, Laplaud P M, Guérin M, Dolphin P, Bruckert E. LDL subfractions: properties and functions. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994; 109 (1,2): 350-351.

Bunce T, Bruckdorfer K R, Rice-Evans C, Timmis A D, Winterton S J, Balcon R, Davies S W. LDL from patients with coronary heart disease are more susceptible to oxidation. 62nd EAS Congress Abstracts 1993, pág 13.

Colquhoun D M, Kroon P A, Will P M, Hicks B J, Davidson M. Susceptibility of LDL to ion-dependent oxidation and extent of coronary atherosclerosis. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994; 109 (1,2): 51.

Mezzeti A, Lapenna D, Pierdomenico S D, Porreca E, Calafíore A M, Riario-Sforza G, lmbastaro T, Cuccurullo F. Systemic oxidative stress status in patients with ischemic heart disease. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994; 109 (1,2): 55-56.

Grieve G, O'Neal D, Nuckey T, Lewicki J, Matthews P G, Sikaris K, Best J. Negative correlation of LDL oxidative resistance with peripheral vascular disease. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis I 994: 109 (1,2): 50.

Krauss R, Lusis A, Rotter J. Genetic and metabolic influences on LDL subclasses. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994; 109 (1,2): 351.

Bergmark C, Wu R, Faire U, Lefvert A K, Swedenborg J. Patients with early-onset peripheral vascular disease have increased leveis of autoantibodies agaisnt oxidized LDL. Arterioscl Thromb Vasc Biol 1995: 15: 441-445.

Andrews B, Burnand K, Paganga G, Browse N, Rice-Evans C, Sommerville K, Leake D, Taub N. Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis 1995; 112: 77-84.

Rijke Y, Jukema J, Zwinderman A, Vogelezang C, Berkel Th, Boven A, Laarse A. Oxidation resistance of low-density lipoprotein is related to progression of coronary atherosclerosis in men with stable angina pectoris.66th EAS Congress' Abstracts 1996, p37.

Vijver L, Steyger R, Poppel G, Boer J, Kruijssen D, Seidell J, Princen H. Autoantibodies against MDL-LDL in subjects with sevre and minor atherosclerosis and healthy population contrais. Atherosclerosis 1996; 122: 245-253.

Chait A, Chang M, Sasahara M, Raines E, Ross R. Oxidative modification of lipoproteins and their treatment in primates. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994; I 09 ( 1,2): 84-85.

Kouzuma R, Tasaki H, Komura T, Nakashima Y, Kuroiwa A. Combined treatment with probucol and diltiazem regresses atherosclerosis induced by 1 % cholesterol diet in rabbit aorta. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1994; 109 ( 1,2): 93.

Yamamoto A, Hara H, Takaichi S, Wakasugi J 1, Tomikawa M. The effect of probucol on machophages, leading to regression of xanthomas and atheromatous vascular lesions. Am J Cardiol 1988; 62: 31B-368.

Anderson T J, Meredith I T, Yeung AC, Frei B, Selwyn A P, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488-493.

Gaziano J, Manson J, Branch L, Colditz G, Willett W, Buring J. Aprospective study of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 1995; 5: 255-260.

Gey K F, Moser U K, Jordan P, Stahelin H B, Eichholzer M, Lüdin E. lncreased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993; 57 (suppl): 787S-797S.

Hennig B, McClain C J, Diana J N. Function of vitamin E and Zinc in maintaining endothelial integrity. lmplications in atherosclerosis. Annals 'N York Acad Se 1993; 686: 99-111.

Hertog M, Feskens E, Hollman P, Katan M B, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancei 1993; 342: 1007-1011.

Luoma P V, Nliyha S, Sikkila K, Hassi J. High serum alpha­ tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland. Am J Med 1995; 237: 49-54.

Pandey D, Shekelle R, Selwyn B, Tangney C, Stamler J. Dietary vitamin C and beta-carotene and risk of death in middle-aged men. The Western Electric Study. Am J Epidemio! 1995; 142: 1269-1278.

Parker R A, Sabrah T, Cap M, Gil! B T. Relation of vascular oxidative stress, a-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscl Thromb Vasc Biol 1995; 15: 349-358.

Steinberg D. Antioxidant vitamins and coronary heart disease. N Engl J Med 1993; 328: 1487-1489.

Land W, Schneeberger H, Schleibner S, lllner W-D, Abendroth D, Rutili G, Arfors K E, Messmer K. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplant 1994; 57: 211-217.

Huttunen J K, Albanes D, Heinonen O P, Taylor P R, Virtamo J, Edwards B K, Rautalahti M, Haapakoski J, Pietinen P, Palmgren J, Greenwald P. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study, a controlled triai with antioxidant vitamins:

results for cancer and ischemic heart disease. Xth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclcrosis 1994: 109 (1,2) 181.

Johansson J, Olsson A, Bergstrand L, Schafcr-Elinder L, Nilsson S, Erikson U, Molgaard J, Holme 1, Walldius G. Lowering of HDL2b by probucol partly expiais thc failure of lhe drug to affect femoral atherosclerosis in subjccts with hypercholestcrolemia. A probucol quantitative regression swedish trial (PQRST) report. Arterioscl Thromb Vasc Biol 1995: 15: 1049-1056.

Kleinvcld H A. Hak-Lemmcrs 11 L. Hectors M P. Fouw N J, Demacker P N. Stalenhocf A r-. Vitamin E and J'atty acid intervention does not attenuate the progression of atherosclerosis in watanabe heritable hyperlipidemic rabbits. Arterioscl Thromb Vasc Biol 1995; 15: 290-297.

Rapola J M, Virtamo J, Haukka J K. Hcinonen O, Albanes D, Taylor P, lluttunen J. Ellect of vitamin E and beta carotene on lhe incidence of angina pectoris. JAMA 1996; 275: 693-698.

Gordon T et al. Menopause and coronary heart disease: lhe Framingham Study. Ann lntern Med 1978; 89: 157-161.

Niki E, Minamisawa, Oikawa M. Komura E. Membrane damage from lipid oxidation induced by free radicais and cigarette smoke. Ann N York Acad Se 1993; (686): 29-38.

Greenberg E. Sporn M. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med 1996; 334: 1189-1190.

Thomas S, Neuzil J, Stocker R. Cosupplementation with coenzyme Q prevenis the prooxidant eftect of a-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscl Thromb Vasc Biol 1996; 16: 687-696.

Maxwell S R J. Can anti-oxidants preveni ischaemic heart disease?. J Clin Pharm Therap 1993: 18: 85-95.

Diaz M, Frei B, Vita J, Keaney J. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408-416.

íloyd H C, Gown A M Wolfbauer G, Chait A. Direct evidencc for a protcin rccognized by a monoclonal antibody against oxidatively modified LDl. in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 1989: 135: 815-825.

Haberland M E, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of watanabe heritable hyperlipidemic rabbits. Science 1988; 241: 215-218.

Witztum J L. Role of oxidised low density lipoprotein in atherogenesis. Br Heart J 1993; 69 (suppl): S12-S18.

YHI-Hcrttuala S, Palinsky W, Rosenfeld M E, Parthasarathy S, Carcw T E, Butlcr S, Witztum J L, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin lnvest 1989; 84: 1086-1095.

Witztum J L. The oxidation hypothesis of atherosclerosis. Lancei 1994: 344: 793-795.

Kummcrow F A. Nutrition imbalance and angiotoxins as dietary risk factors in coronary heart discase. Am J Clin Nutr 1979; 32: 58-83.

Morei D W. 1 lessler J R, Chisolm G M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983, 24: 1070-1076.

Norata G, Roma P, Catapano A. Oxidized LDL induce apoptosis in human. endothelial cells. Xlth lnternational Symposium on Atherosclerosis' Abstracts, Atherosclerosis 1997; 134 (1,2): 245.

Oikninc J, Aviram M. Oxidation of cellular lipid lcads to macrophage activation. 62nd EAS Congress Abstracts 1993, pág 16.

Steinberg D. Antioxidants and atherosclerosis: a current assessment. Circulation 1991: 84: 1420-1425.

Zwijsen R M L, Japenga S C, Heijen A M P, van den Bos R C. Koeman J H. Oxidized LDL induces PDGF-A gene expression in human smooth muscle cells. 62nd EAS Congress Abstracts 1993, pág 139.

Maier J A M, Barenghi L, Massardi M L, Pagani F, Statuto M, Bradam ante. S, Ragnotti G. HDL prevenis oxidized LDL induction of monocyte endothclial interactions. 62nd EAS Congress Abstracts 1993, pág 58.

Steinberg D, Witztum J L. Lipoproteins and atherogenesis. Current concepts" JAMA 1990; 264: 3047-3052.

Stemme S, Faber 13, Holm J, Hansson G K. Evidence for a local, cell-mediated autoimmune response to oxidized LDL in thc human atherosclerotic plaque. 62nd EAS Congress Abstracts 1993, púg 131.

Vita J A, Treasur C B, Nabel 14 C, McLenachan J M, Fish R D. Yeung A C, Vekshtein V L Selwyn A P, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-497.

Gryglewski R J, Palmer R M J, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-456.

Hogg N, Darley-Usmar V M, Graham A, Moncada S. Peroxynitrite and atherosclerosis. Biochemical Society Transactions 1992; 21: 358-362.

Penn M S. Chisolm G. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis 1994; 108 (suppl): S2 l -S29.

Berliner J A, Territo M C, Sevanian A, Ramin S, Kim J A, Bamshad B, Esterson M, Fogelman A M. Minimally moditied low density lipoprotein stimulates monocyte endothelial interactions. J Clin lnvest 1990; 85: 1260-1266.

Maclsaac A 1, Thomas J D, Topoi E J. Toward lhe quiescent coronary plaque. JACC 1993; 22: 1228-1241.

Rajavashisth T B, Andalibi A, Territo M C, Berliner J A, Navab M, Fogelman A M, Lusis A J. lnduction of endothelial cell expression of granulocyte and monocyte-macrophage chemotatic factors by modified low density lipoproteins. Nature 1990: 344: 254-257.

Weidtmann A, Scheilte R, Hrboticky N, Pietsch A, Lorenz R, Siess W. Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2. Arterioscl Thromb Vasc Biol 1995; 15: 1131-1138.

Witztum J L. Role of oxidised low density lipoprotein in atherogenesis. Br Heart J 1993; 69 (suppl): S12-S18.

Juliano L, Signore A, Vallabajosula S, Colavita A, Camastra C, Ronga G, Alessandri C, Sbarigia E, Fiorani P, Violi F. Preparation and biodistribution of 99mtechnetium labelled oxidized LDL in man" Atherosclerosis 1996; 126: 131-141.

Pi tas R E, Boyles J, Mahley R W, Bissell D M. Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells. J Cell Biol 1985; 100: 103-117.

Pech M A, Myara 1, Moatti N. Effects of smoking on LDL modifications by endothelial cells. 62nd EAS Congress Abstracts 1993, pág 59.

Esterbauer H, Wag G, Puhl 1-1. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993: 49: 566-576.

Biache D, Rodriguez C, Davignon J. Platelet-induced oxidative LDL modification. Xth lnternational Symposium on Atherosclerosis Abstracts, Atherosclerosis 1994: 109 (1,2): 42.

Weber C, Erl W, Weber K, Weber PC. lncreased adhesiveness of isolated monocytes to endothelium id prevented by vitamin C intake in smokers. Circulation 1996; 93: 1488-1492.

Levine G N, Frei B, Koulouris S N, Gerhard M D, Keaney J F, Vita J A. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93: 1107-1113.

Ficheiros Adicionais

Publicado

31-03-2000

Como Citar

1.
Silva JM, Devesa N, Gaspar E. Patogénese da aterosclerose 1ª parte. RPMI [Internet]. 31 de Março de 2000 [citado 30 de Maio de 2024];7(1):42-54. Disponível em: https://revista.spmi.pt/index.php/rpmi/article/view/1969

Edição

Secção

Artigos de Revisão

Artigos mais lidos do(s) mesmo(s) autor(es)

1 2 3 > >>